Wu Jin-Tao, Wang Shan-Ling, Chu Ying-Jie, Long De-Yong, Dong Jian-Zeng, Fan Xian-Wei, Yang Hai-Tao, Duan Hong-Yan, Yan Li-Jie, Qian Peng
Department of Cardiology, Henan Provincial People's Hospital (Zhengzhou University People's Hospital).
J Atheroscler Thromb. 2017 Feb 1;24(2):176-184. doi: 10.5551/jat.34900. Epub 2016 Jun 15.
To evaluate the role of CHADS and CHADS-VASc scores in predicting the risk of ischemic stroke or transient ischemic attack (TIA) outcomes in patients with interatrial block (IAB) without a history of atrial fibrillation (AF).
A retrospective study was conducted, including 1,046 non-anticoagulated inpatients (612 males, 434 females; mean age: 63±10 years) with IAB and without AF. IAB was defined as P-wave duration >120 ms using a 12-lead electrocardiogram. CHADS and CHADS-VASc scores were retrospectively calculated. The primary outcomes evaluated were ischemic stroke or TIA.
During the mean follow-up period of 4.9±0.7 years, 55 (5.3%) patients had an ischemic stroke or TIA. Receiver operating characteristic (ROC) curve analysis showed that the CHADS score [area under the curve (AUC), 0.638; 95% confidence interval (CI), 0.562-0.715; P=0.001] and the CHADS-VASc score (AUC, 0.671; 95% CI, 0.599-0.744; P<0.001) were predictive of ischemic strokes or TIA. Cut-off point analysis showed that a CHADS score ≥3 (sensitivity=0.455 and specificity=0.747) and a CHADS-VASc score ≥4 (sensitivity=0.564 and specificity=0.700) provided the highest predictive value for ischemic stroke or TIA. The multivariate Cox regression analysis showed that CHADS [hazard ratio (HR), 1.442; 95% CI, 1.171-1.774; P=0.001] and CHADS-VASc (HR, 1.420; 95% CI, 1.203-1.677; P<0.001) scores were independently associated with ischemic stroke or TIA following adjustment for smoking, left atrial diameter, antiplatelet agents, angiotensin inhibitors, and statins.
CHADS and CHADS-VASc scores may be predictors of risk of ischemic stroke or TIA in patients with IAB without AF.
评估CHADS和CHADS-VASc评分在预测无房颤病史的房间阻滞(IAB)患者发生缺血性卒中或短暂性脑缺血发作(TIA)结局风险中的作用。
进行一项回顾性研究,纳入1046例无房颤的IAB非抗凝住院患者(男性612例,女性434例;平均年龄:63±10岁)。IAB定义为使用12导联心电图时P波时限>120毫秒。回顾性计算CHADS和CHADS-VASc评分。评估的主要结局为缺血性卒中或TIA。
在平均4.9±0.7年的随访期内,55例(5.3%)患者发生缺血性卒中或TIA。受试者工作特征(ROC)曲线分析显示,CHADS评分[曲线下面积(AUC),0.638;95%置信区间(CI),0.562 - 0.715;P = 0.001]和CHADS-VASc评分(AUC,0.671;95% CI,0.599 - 0.744;P<0.001)可预测缺血性卒中和TIA。截断点分析显示,CHADS评分≥3(敏感性 = 0.455,特异性 = 0.747)和CHADS-VASc评分≥4(敏感性 = 0.564,特异性 =
0.7)对缺血性卒中或TIA具有最高预测价值。多因素Cox回归分析显示,在对吸烟、左心房直径、抗血小板药物、血管紧张素抑制剂和他汀类药物进行校正后,CHADS[风险比(HR),1.442;95% CI,1.171 - 1.774;P = 0.001]和CHADS-VASc(HR,1.420;95% CI,1.203 - 1.677;P<0.001)评分与缺血性卒中或TIA独立相关。
CHADS和CHADS-VASc评分可能是无房颤的IAB患者发生缺血性卒中或TIA风险的预测指标。